T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E. Josefsson, June H. Myklebust, Kanutte Huse et al.|Clinical Cancer Research|2017Cited by 95
Efficient chimeric antigen receptor targeting of a central epitope of CD22Nicholas Casey, Sébastien Wälchli, June H. Myklebust et al.|Journal of Biological Chemistry|2023Cited by 6
Data from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E. Josefsson, June H. Myklebust, Kanutte Huse et al.|Unknown|2023Cited by 0
Supplementary figures 1-9 from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E. Josefsson, June H. Myklebust, Arne Kolstad et al.|Unknown|2023Cited by 0
Supplementary methods and references, Supplementary Figures 1-9 from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E. Josefsson, June H. Myklebust, Kanutte Huse et al.|Unknown|2023Cited by 0